Concepedia
Statistics
Publications
77
Citations
5K
H-Index
40
Active since
1973
Affiliations
Thomas Jefferson University(Current)
Sidney Kimmel Cancer Center
Jefferson College
Wills Eye Hospital
David Berd is an author at Thomas Jefferson University specializing in oncology, medicine, and immunology.
Publications per year
1973–2015
Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients.
David Berd, Henry Maguire, Peter A. McCue et al. · Journal of Clinical Oncology · 1990 · 298 citations
Medicine, Immunology, Oncology +17
Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide.
David Berd, Henry Maguire, Michael J. Mastrangelo · PubMed · 1986 · 252 citations
Life Sciences, Immunology, Oncology +17
Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma.
Masataka Ohta, Hirokazu Nagai, Makiko Shimizu et al. · PubMed · 1994 · 169 citations
Life Sciences, Genetics, Molecular Genetics +17
Laboratory Identification of Clinically Important Aerobic Actinomycetes
David Berd · Applied Microbiology · 1973 · 167 citations · Full text
Life Sciences, Microbiology, Diagnostic Microbiology +6
Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+, 2H4+ suppressor-inducer T-cells.
David Berd, Michael J. Mastrangelo · PubMed · 1988 · 167 citations
1–5 of 77